CClinicalTrials.gg
RecruitingNCT07754656Updated Aug 10, 2026

Adapted Cardiopulmonary Resuscitation Study

An interventional study of aCPR algorithm and ERC ALS 2025 in Cardiac Arrest (CA), sponsored by Johannes Kepler University of Linz. Recruiting at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Johannes Kepler University of Linz · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
216
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this controlled single centre RCT is to compare frequency rates concerning return of spontaneous circulation (ROSC) in prehospital cardiac arrest. Two different algorithms (control-and interventiongroup) of advanced cardiac life support will be used to treat patients. In patients over 18 years suffering from cardiac arrest. The main question aims to answer if the frequency of ROSC differs between the groups receiving either the new Advanced Life Support (ALS) algorithm, or standard treatment.

Researchers will compare the new algorithm to the standard care algorithm to see if there is a difference .

Participants will be randomized to treatment on scene. The controlgroup will receive ALS standard treatment as performed in local protocols.

The intervention group will receive a modified treatment including:

  • thorax compression via mechanical device (LUCAS 3)
  • head up Cardiopulmonary Resuscitation (cpr)
  • use of an impendance threshold device (ITD) module
  • arterial line placement
  • continuous epinephrin infusion via infusion pump
  • double sequence defibrillation
02

Conditions studied

  • Cardiac Arrest (CA)

Browse trials for

Keywords

  • cardiac arrest
  • head up cpr
  • continuous adrenalin infusion
  • mechanical thorax compression
  • ITD
  • arterial line
  • diastolic blood pressure
  • ROSC
  • OHCA
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age> 18 years
  • time of resuscitation \<21 minutes when enrollement starts

Exclusion criteria

Exclusion Criteria:

  • obvious pregnancy
  • contraindications for the use of Lucas 3
  • time of resuscitation >21 minutes and etCO2 \<15 mmHg upon arrival of the emergency physician on scene
  • Exclusion from the emergency physician from study due to futility.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
216 participants (estimated)

Study arms

  • Active comparator
    ALS ERC 2025

    Procedure: ERC ALS 2025

  • Experimental
    adapted CPR algorithm

    * thorax compression via mechanical device (LUCAS 3) * head up cpr * use of an ITD module * arterial line placement * continuous epinephrin infusion via infusion pump * double sequence defibrillation

    Procedure: aCPR algorithm

Interventions

  • ProcedureaCPR algorithm

    * thorax compression via mechanical device (LUCAS 3) * head up cpr * use of an ITD module * arterial line placement * continuous epinephrin infusion via infusion pump * double sequence defibrillation

  • ProcedureERC ALS 2025

    Placement of an IV line, placement of a supraglottic airway device or endotracheal intubation. Optional use of an intraosseus acces

05

What researchers measure

Primary outcomes

  1. ROSC

    frequency of ROSC in the study cohort

    Time frame: one minute

Secondary outcomes

  1. Time to ROSC

    comparison between the groups if ROSC can be achieved faster in one group

    Time frame: Periprocedural: from enrollement to ROSC or Termination of Resuscitation (TOR)

  2. CO2

    Measurement of CO2 differences between study arms

    Time frame: Periprocedural: from enrollement to ROSC orTOR

  3. descriptive data

    analyzing vital parameters measured

    Time frame: Periprocedural: during study intervention

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No — Deidentified participant data utilized in this study can be made available upon reasonable request to the corresponding author. Access to the data will be subject to approval by institutional and ethical considerations.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07754656
Lead sponsor
Johannes Kepler University of Linz
Collaborators
Red Cross Upper Austria, Kepler University Hospital
Responsible party
Sponsor
First posted
Aug 10, 2026
Start date
Jan 28, 2026
Primary completion
Jan 28, 2029 (estimated)
Completion
Mar 28, 2029 (estimated)
Last update
Aug 10, 2026

Study contacts

Jens Meier, Univ. Prof.
principal investigator · Kepler University Hospital / Johannes Kepler University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion